Soru

Zorluk: Çok zorPreventive Care and Immunizations

A couple brings their 8-month-old son to the pediatric clinic for a pre-travel consultation. They are scheduled to relocate temporarily to a rural region in Sub-Saharan Africa in two weeks. This region currently has high endemic rates of both measles and hepatitis A. The boy was born prematurely at 32 weeks gestation following an uncomplicated pregnancy and neonatal course. His routine immunizations are up to date according to his chronological age. The parents report that he has had mild nasal congestion and a clear nasal discharge for the past two days. On examination, his temperature is 37.6°C (99.7°F). He is playful, well-appearing, and in no respiratory distress. Neurologic examination reveals that he is able to roll from back to front and sits leaning forward on his hands, but he falls over when his hands are removed. Which of the following is the most appropriate management plan for this patient today?

  1. Administer measles-mumps-rubella (MMR) and hepatitis A vaccines, and advise that both will need to be re-administered starting at age 12 monthsCevap
  2. B
    Administer MMR and hepatitis A vaccines, and advise that these doses will serve as the first of their respective routine pediatric series
  3. C
    Administer the hepatitis A vaccine only, and defer the MMR vaccine because live-attenuated vaccines are contraindicated prior to 12 months of age
  4. D
    Defer all immunizations due to the presence of an acute respiratory infection, and prescribe oral amoxicillin
  5. E
    Defer travel immunizations to minimize physiological stress, and refer the child for early intervention due to gross motor delay

Cevap

Administer measles-mumps-rubella (MMR) and hepatitis A vaccines, and advise that both will need to be re-administered starting at age 12 months
The most appropriate management is to administer both the MMR and hepatitis A vaccines today, and advise the parents that these doses will need to be repeated starting at 12 months of age. According to current pediatric immunization guidelines, infants aged 6 to 11 months who are traveling internationally to highly endemic areas should receive one dose of the MMR vaccine and one dose of the hepatitis A vaccine prior to departure. However, because circulating maternal antibodies can blunt the infant's immune response, doses administered before 12 months of age do not provide reliable long-term immunity and do not count toward the routine pediatric immunization series. Furthermore, the infant's mild upper respiratory infection is a false contraindication to vaccination, and his developmental milestones (rolling, tripod sitting) are perfectly normal for his corrected gestational age of 6 months.

Adım Adım Çözüm

1
Evaluate the patient's travel risk and age-based vaccine indications.
The patient is 8 months old and traveling to a highly endemic area for measles and hepatitis A.
Infants aged 6 to 11 months are at high risk for severe complications from measles and hepatitis A during international travel, prompting specific early vaccination protocols.
2
Determine if the early vaccine doses will count toward the standard pediatric series.
Doses given before 12 months of age do not count toward the routine series.
Circulating maternal IgG antibodies in infants under 12 months can neutralize the vaccine antigens, preventing the formation of a robust, long-lasting memory B-cell response.
3
Assess the patient's developmental milestones based on his prematurity.
Chronological age is 8 months; corrected age is 6 months (born at 32 weeks). Tripod sitting is a normal 6-month milestone.
Premature infants are assessed for developmental milestones based on their corrected gestational age to avoid false diagnoses of developmental delay.
4
Assess the patient's current mild illness as a potential vaccine contraindication.
The patient has a mild viral upper respiratory infection, which is a false contraindication.
Mild acute illnesses, with or without low-grade fever, do not significantly impair the immune response to vaccines or increase the risk of adverse vaccine reactions.

Anahtar Kavram

Immunization management for international travel in premature infants
Tahmini Süre:2m 0s
Bu soruyu puanla